Alsynth Remedies Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 16-12-2024
- Paid Up Capital ₹ 7.50 M
as on 16-12-2024
- Company Age 40 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.43 Cr
as on 16-12-2024
- Revenue 37.02%
(FY 2022)
- Profit -21.81%
(FY 2022)
- Ebitda 15.31%
(FY 2022)
- Net Worth 2.59%
(FY 2022)
- Total Assets -13.46%
(FY 2022)
About Alsynth Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company has closed loans amounting to ₹1.43 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dandu Raju, Dandu Prashanth, Dandu Lakshmi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231TG1984PLC004955
- Company No.
004955
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Sep 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alsynth Remedies Ltd offer?
Alsynth Remedies Ltd offers a wide range of products and services, including Ayurvedic Digestive Medicine, Digestive Tonic, Ayurvedic Joint Pain Relief Medicine, Herbal Joint Pain Relief Tablets, Pharmaceutical Capsules, Prostate Care Capsules, Body Powder, Talcum Powder, Weight Loss Supplement, Slim Fit Capsules.
Who are the key members and board of directors at Alsynth Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dandu Raju  | Managing Director | 05-Sep-1984 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dandu Prashanth | Director | 08-Apr-2002 | Current |
| Dandu Lakshmi | Director | 08-Apr-2002 | Current |
| Dandu Devi | Director | 23-Feb-2015 | Current |
Financial Performance of Alsynth Remedies.
Alsynth Remedies Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 37.02% increase. The company also saw a substantial fall in profitability, with a 21.81% decrease in profit. The company's net worth moved up by a moderate rise of 2.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alsynth Remedies?
In 2020, Alsynth Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
A.P State Financial Corporation Creation Date: 31 Mar 2008 | ₹2.09 M | Satisfied |
A.P State Financial Corporation Creation Date: 14 Mar 2007 | ₹1.32 M | Satisfied |
A P State Financial Corporation Creation Date: 18 Jun 2002 | ₹2.00 M | Satisfied |
How Many Employees Work at Alsynth Remedies?
Alsynth Remedies has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alsynth Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alsynth Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
